Invyncible review
Invyncible is a Florida-based telehealth platform that prices every semaglutide and tirzepatide program on its open catalog and names the six compounding pharmacies that fill them.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $149/mo (0.45 mg dose, compounded with glycine + B12) — $50 below our category median of $199.
- Semaglutide
- $149/mo (0.45 mg dose, compounded with glycine + B12)
- Tirzepatide
- $180/mo (2.5 mg weekly, 4-week program, compounded)
- Coverage
- 46 states plus DC
- Brand-name
- Yes
- Oral option
- Yes
- Verification
- Not independently listed
Best for: People who want to read the price of every dose program, and the name of the pharmacy behind it, before starting an intake.
MatchScript's take: Our #302 pick of 537 — priced at or below the category median.
The factor breakdown
Invyncible on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $149/mo (0.45 mg dose, compounded with glycine + B12) puts Budget Fit at a below-par 62 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 62 on Speed to Start.
Invyncible adds an oral/sublingual route and brand-name access on top of injectables, for a below-par 72 on Formulary Match.
Support lands at a below-par 67 — lighter, meds-first support.
Flexibility scores a below-par 61 — fewer levers to flex your plan.
Thinner public disclosure than the top of the ranking keeps Transparency at a below-par 46.
Pricing in context
How Invyncible's monthly price sits against the category median and the cheapest provider we track.
| Monthly price | Semaglutide | Tirzepatide |
|---|---|---|
| Invynciblethis providerVisit | $149/mo (0.45 mg dose, compounded with glycine + B12)−$50 vs median | $180/mo (2.5 mg weekly, 4-week program, compounded)−$94 vs median |
| Category median430 tracked | $199/mo | $274/mo |
| Cheapest trackedMondaeVisit | $87 per 28 days (13 charges a year) | $126 per 28 days (13 charges a year) |
What we like
- Every dose program is priced on the open catalog — no account, no intake, no quiz — and each product page re-prices as you change dose
- Names all six compounding pharmacies with street addresses and phone numbers, and lets the patient pick which one fills the prescription
- Separates compounded from FDA-approved brand and injection from oral on the catalog itself — Wegovy $1,750, Zepbound $1,540, semaglutide capsules $255.50
- Refills are requested rather than auto-billed, and the card is only charged if a provider approves the prescription
- Corporate parent disclosed (Nationwide Telemedicine, LLC) with a St. Petersburg, FL address and a working, domain-specific LegitScript link
The caveats
- The entry figure is the smallest vial — plain compounded semaglutide runs $192.50, $262.50 and $350 across its three vial sizes, and the FAQ confirms cost rises with dose
- Every price is shown against a permanent struck-through list figure, which is anchoring rather than a saving
- 503A vs 503B designation not stated for any of the six named pharmacies
- Shipping is charged at checkout with the amount published nowhere, and every GLP-1 is locked to overnight cold shipping
- Compounded semaglutide is unavailable in six more states than the 46-state footprint, tirzepatide in seven, and support is weekday business hours only
Who it's for — and who should skip it
Invyncible is for people who want to read the price of every dose program, and the name of the pharmacy behind it, before starting an intake.
Skip it if that doesn't sound like you. A closer fit may be SkinnyRx (Match Score 64) — or take the quiz to see where Invyncible lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Invyncible against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Invynciblethis provider | CoreAge Rxour #1 | FORM (by GBY)closest scorer |
|---|---|---|---|
| Sema price | $149/mo (0.45 mg dose, compounded with glycine + B12) | $99/mo at every dose | $299/mo compounded (no dose tiers) |
| Coverage | 46 states plus DC | All 50 states | 48 states plus D.C. (excludes Alaska and Mississippi) |
| Formulary | Injectable + oral + brand | Injectable | Injectable + oral + brand |
| Match Score | 62 · C | 91 · A− | 62 · C |
Invyncible, answered
Is Invyncible legit?
Invyncible is a real, operating GLP-1 telehealth program. LegitScript certification is the third-party check worth asking for — look for the seal on their site and confirm your prescriber is US-licensed at intake. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved.
How much does Invyncible cost?
Invyncible lists compounded semaglutide from $149/mo (0.45 mg dose, compounded with glycine + B12) and tirzepatide from $180/mo (2.5 mg weekly, 4-week program, compounded) — below our category median of $199/mo. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does Invyncible ship to my state?
Almost certainly — Invyncible reports near-nationwide coverage (46 states plus DC). Check the exclusions before you pay.
Invyncible vs SkinnyRx — which should I pick?
They score within a few points of each other: Invyncible at 62/100 and SkinnyRx at 64/100, so neither wins on the headline number. Invyncible is the better fit for people who want to read the price of every dose program, and the name of the pharmacy behind it, before starting an intake. SkinnyRx suits shoppers who want a tablet as well as an injection on either molecule, and who read the term attached to an advertised rate before they read the number. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from Invyncible's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Invyncible's site. Not medical advice; see our disclosure.
Semaglutide here is $149/mo (0.45 mg dose, compounded with glycine + B12) — $50 below our category median of $199. Tirzepatide is $180/mo (2.5 mg weekly, 4-week program, compounded). Its strongest suit is the range of medication it offers. Best suited to people who want to read the price of every dose program, and the name of the pharmacy behind it, before starting an intake. If that is not you, SkinnyRx is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Invyncible here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Trinity Meds#303 | 62 | $99/mo | $149/mo | Coverage not published | Alternatives | Visit |
| Valhalla Vitality#304 | 62 | $108/mo | $100/mo | Coverage not published | Alternatives | Visit |
| Superior Remedies#305 | 62 | $202/mo | $303/mo | 7 states — CA, IL, MI, NY, UT, VA, WI | Alternatives | Visit |
| Magnolia Regenerative Medicine#306 | 62 | $119/mo | $199/mo | 26 states | Alternatives | Visit |
| RENN Health#307 | 62 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Try Ageless#308 FDA issued Lovely Meds, Inc. dba Lovely Meds a warning letter in September 2025. See FDA's warning-letter database. | 59 | $279/mo (injection, month-to-month) | $349/mo (injection, month-to-month) | Coverage not published | Alternatives | Visit |
| LevelsRx#309 | 61 | $253/mo | $354/mo | Coverage not published | Alternatives | Visit |
| Livv#310 | 61 | $179/mo | $269/mo | Coverage not published | Alternatives | Visit |
| Clinic Secret#311 | 61 | $301/mo | $403/mo | Coverage not published | Alternatives | Visit |
| Heva Health#312 | 61 | $199/mo | Not disclosed | Coverage not published | Alternatives | Visit |
| InstaRX#313 | 61 | $252/mo | $353/mo | All 50 states | Alternatives | Visit |
| Tuyo Health#314 FDA issued Tuyo Health, Inc. dba Tuyo Health a warning letter in September 2025. See FDA's warning-letter database. | 61 | $155/mo | $349/mo | Coverage not published | Alternatives | Visit |
| MyStart Health#315 FDA issued Matthew Stern, CEO MyStart Health LLC. a warning letter in September 2025. See FDA's warning-letter database. | 61 | $303/mo | $303/mo | Coverage not published | Alternatives | Visit |
| Freya Meds#316 | 61 | $301/mo | $396/mo | Coverage not published | Alternatives | Visit |
| The Aesthetic Concierge#317 | 61 | $417/mo | Not disclosed | 13 states | Alternatives | Visit |
| BeyondMD#318 | 61 | $139/mo (starting dose, compounded) | $209/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| FuturHealth#319 | 61 | $199/mo (compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Human+#320 | 61 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| iThriveMD#321 | 61 | $325/mo | $434/mo | Coverage not published | Alternatives | Visit |
| Noom Med#322 | 61 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Transparent Meds#323 | 61 | $229/mo (promotional rate, compounded) | $349/mo (compounded) | Coverage not published | Alternatives | Visit |
| WeightWatchers Clinic#324 | 61 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Carocare Wellness#325 | 61 | $152/mo | $203/mo | 1 state | Alternatives | Visit |
| Dr. Arevitalize#326 | 61 | $269/mo | $359/mo (compounded) | Coverage not published | Alternatives | Visit |
Invyncible is ranked on our best semaglutide providers, best tirzepatide providers, best GLP-1 programs, best brand-name GLP-1 providers and best oral GLP-1 providers boards, scored on the same six factors as every other provider there.